Future research should focus on identifying sources of heterogeneity, exploring the impact of different IL-6 thresholds, and considering the use of IL-6 as part of a multi-marker panel, or in specific patient subgroups, to unlock its potential in refining sepsis prognosis and guiding personalized treatment decisions. The gene discussed is IL6; the disease is Sepsis.